On September 24, 2024, Amgen, Inc. filed a notice of data breach with the Attorney General of Massachusetts after discovering that confidential information that was provided to the company was subject to unauthorized access after an incident at Sirva Relocation, LLC (“Sirva”). In this notice, Amgen explains that the incident resulted in an unauthorized party being able to access sensitive information belonging to certain individuals, including their names, Social Security numbers, financial account information, employment information, medical information, contact information and dates of birth. Upon completing its investigation, Amgen began sending out data breach notification letters to all individuals whose information was affected by the recent data security incident.
If you received a data breach notification from Amgen, it is essential you understand what is at risk and what you can do about it. A data breach lawyer can help you learn more about how to protect yourself from becoming a victim of fraud or identity theft, as well as discuss your legal options following the Amgen / Sirva data breach. For more information, please see our recent piece on the topic here.
What Caused the Amgen / Sirva Data Breach?
The Amgen / Sirva data breach was only recently announced, and more information is expected in the near future. However, Amgen’s filing with the Attorney General of Massachusetts provides some important information on what led up to the breach. According to this source, on September 29, 2023, Sirva became aware of suspicious activity within its computer network. In response, Sirva launched an investigation, which ultimately confirmed that an unauthorized party was able to access portions of its IT network between August 16, 2023 and October 17, 2023. During this period, certain files containing confidential information that had been provided to Sirva by Amgen were copied by the unauthorized actor.
After learning that sensitive consumer data was accessible to an unauthorized party, Sirva reviewed the compromised files to determine what information was leaked and which consumers were impacted. On August 24, 2024, Sirva informed Amgen of the incident, as well as the fact that information Amgen provided to Sirva was among the leaked data. While the breached information varies depending on the individual, it may include your name, Social Security number, financial account information, employment information, medical information, contact information and date of birth.
On September 24, 2024, Amgen sent out data breach letters to anyone who was affected by the recent data security incident. These letters should provide victims with a list of what information belonging to them was compromised.
More Information About Amgen
Amgen Inc. is a biotechnology company with headquarters in Thousand Oaks, California. Amgen’s top-selling products are Enbrel, which is used in the treatment of rheumatoid arthritis and other autoimmune diseases, and Neulasta, which is used to prevent infections in patients undergoing cancer chemotherapy. Amgen employs more than 26,700 people and generates approximately $29.5 billion in annual revenue.
